NRAS and melanoma: Considering that BRAF and NRAS mutant melanomas are prone to an ominous prognostic outcome [35, 36], the similar gene expression signature pattern of the wild-type and mutant melanomas indicates that our model-based classification could accurately identify patients with unfavorable prognoses regardless of the BRAF and NRAS status.